Downregulation of miR-29b-3p aggravates podocyte injury by targeting HDAC4 in LPS-induced acute kidney injury

被引:19
|
作者
Ha, Zong-Lan [1 ]
Yu, Zi-Ying [2 ]
机构
[1] Qinghai Univ, Affiliated Hosp, Dept Crit Care Med, Xining, Peoples R China
[2] First Affiliated Hosp Univ South, Dept Emergency, Chuanshan Rd, Hengyang, Hunan, Peoples R China
来源
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES | 2021年 / 37卷 / 12期
关键词
acute kidney injury; HDAC4; LPS; miR-29b-3p; sepsis; SEPSIS; DYSFUNCTION;
D O I
10.1002/kjm2.12431
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Sepsis is a severe organ dysfunction disease, usually accompanied by acute kidney injury (AKI). miR-29b-3p was inhibited in sepsis-induced AKI, while its role in AKI was unclear. Therefore, this study determined the role of miR-29b-3p in sepsis-induced AKI, and investigated its underlying mechanism. In this study, the AKI model was established through injecting with lipopolysaccharides (LPS) intraperitoneally. In LPS challenged mice, serum blood urea nitrogen and creatinine were increased, and renal tissues pathological damage was induced. Besides, miR-29b-3p was declined in LPS-induced AKI mice and podocytes. In addition, HDAC4 was elevated in LPS-treated podocytes. Furthermore, upregulated miR-29b-3p attenuated LPS-induced mice podocyte injury, and HDAC4 was identified as a direct target of miR-29b-3p. Moreover, overexpression of miR-29b-3p attenuated LPS-induced AKI in mice. In conclusion, miR-29b-3p was inhibited in LPS-induced AKI. Downregulation of miR-29b-3p aggravated podocyte injury through targeting HDAC4 in LPS-induced AKI. miR-29b-3p may act as a valuable target for AKI therapy.
引用
收藏
页码:1069 / 1076
页数:8
相关论文
共 50 条
  • [1] MiR-29b-3p aggravates cardiac hypoxia/reoxygenation injury via targeting PTX3
    Dan He
    Lei Yan
    Cytotechnology, 2021, 73 : 91 - 100
  • [2] MiR-29b-3p aggravates cardiac hypoxia/reoxygenation injury via targeting PTX3
    He, Dan
    Yan, Lei
    CYTOTECHNOLOGY, 2021, 73 (01) : 91 - 100
  • [3] Reduced expression of MiR-125a-5p aggravates LPS-induced experimental acute kidney injury pathology by targeting TRAF6
    Yang, Chao
    Yang, Cheng
    Huang, Zhi
    Zhang, Jinxin
    Chen, Nuoer
    Guo, Yingfang
    Zahoor, Arshad
    Deng, Ganzhen
    LIFE SCIENCES, 2022, 288
  • [4] Fractalkine deficiency attenuates LPS-induced acute kidney injury and podocyte apoptosis by targeting the PI3K/Akt signal pathway
    Gong, Qiming
    Ma, Jingxue
    Kang, Hongli
    Pan, Xiuhong
    You, Yanwu
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2022, 26 (08) : 741 - 749
  • [5] MiR-206-3p alleviates chronic constriction injury-induced neuropathic pain through targeting HDAC4
    Wen, Jing
    He, Tao
    Qi, Fangfang
    Chen, Hongping
    EXPERIMENTAL ANIMALS, 2019, 68 (02) : 213 - 220
  • [6] Fractalkine deficiency attenuates LPS-induced acute kidney injury and podocyte apoptosis by targeting the PI3K/Akt signal pathway
    Qiming Gong
    Jingxue Ma
    Hongli Kang
    Xiuhong Pan
    Yanwu You
    Clinical and Experimental Nephrology, 2022, 26 : 741 - 749
  • [7] Downregulation of miR-181a protects mice from LPS-induced acute lung injury by targeting Bcl-2
    Li, Wuquan
    Qiu, Xiaochen
    Jiang, He
    Han, Yalong
    Wei, Dinan
    Liu, Jun
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 84 : 1375 - 1382
  • [8] MiR-150 attenuates LPS-induced acute lung injury via targeting AKT3
    Li, Pibao
    Yao, Yanfen
    Ma, Yuezhen
    Chen, Yanbin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 75
  • [9] miR-504-3p-HNF1B signaling axis aggravates podocyte injury in diabetic kidney disease
    Zhuang, Yibo
    Zhu, Lingtao
    Fu, Chenlu
    Ni, Huiping
    JOURNAL OF MOLECULAR HISTOLOGY, 2025, 56 (02)
  • [10] Fractalkine aggravates LPS-induced macrophage activation and acute kidney injury via Wnt/β-catenin signalling pathway
    Gong, Qiming
    Jiang, Yan
    Pan, Xiuhong
    You, Yanwu
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (14) : 6963 - 6975